What Was Mark Cuban’s Worst ‘Shark Tank’ Financial investment?

Mark Cuban has a built a range of investments in the course of his decade-long stint on ABC’s Shark Tank — some of them better than other people.

In an interview with the Entire Send out podcast final week, Cuban discovered his biggest financial investment loss to date: $500,000 on the Breathometer, a smartphone attachment that entrepreneur Charles Michael Yim pitched as “the world’s initially smartphone breathalyzer” in 2013. Cuban mentioned what went incorrect — and how billionaire entrepreneur Richard Branson was tangentially concerned.

Yim claimed his Breathometer could transmit BAC-level readings to a user’s phone and provide the choice to connect with a taxi if the looking through was also higher. The entrepreneur gave all of the sharks glasses of champagne to take a look at the products for them selves, and all 5 of them had been in — a first in Shark Tank record, for each CNBC Make It — providing Yim $1 million for a 30% stake in his organization.

Connected: The Shark Tank Result: Top rated Success Stories from the To start with 3 Seasons

But Cuban quickly understood he had a problem. “The male – Charles – I would search at his Instagram and he’d be in Bora Bora …,” Cuban instructed Comprehensive Mail. “Two weeks later on, he’d been in [Las] Vegas partying, and then he’d be on Necker Island with Richard Branson.”

When Cuban pressed Yim about his whereabouts and operate ethic, the entrepreneur claimed he was “networking.”

“Future factor you know, all of the money’s gone,” Cuban mentioned.

In 2016, Yim shifted his concentration to Mint, which claimed to evaluate amounts of sulfur compounds in the mouth to consider bad breath — a products that is also not readily available now.

But Yim explained to CNBC Make It that Cuban’s accusation was baseless, as he was on Necker Island to pitch the Breathometer to Richard Branson — who did name the solution a 2015 finalist in his Severe Tech Obstacle Pitch competition.

Nevertheless, it would flip out that the technology was not truly refined ample to assist Yim’s promises. In January of 2017, the Federal Trade Fee filed a complaint from Yim and Breathometer, which it alleged, “lacked scientific evidence to back up their promotion statements.” Breathometer and the FTC arrived at a settlement later on that thirty day period, requiring…